Search research articles
Contact Us
Filters
Showing results (681-690 of 706) with videos related to
Page
of 71
Sort By:
The Canadian Journal of Cardiology
|
August 11, 2018
Simplified Canadian Definition for Familial Hypercholesterolemia
Isabelle Ruel, Diane Brisson, Sumayah Aljenedil, et al.
Journal of Lipid Research
|
April 11, 2025
Statin effects on the lipidome: Predicting statin usage and implications for cardiovascular risk prediction
Changyu Yi, Kevin Huynh, Yvette Schooneveldt, et al.
European Heart Journal
|
August 29, 2022
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement
Florian Kronenberg, Samia Mora, Erik S G Stroes, et al.
The Lancet. Diabetes & Endocrinology
|
April 16, 2014
The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
Robert A Hegele, Henry N Ginsberg, M John Chapman, et al.
European Heart Journal
|
April 27, 2017
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
Brian A Ference, Henry N Ginsberg, Ian Graham, et al.
Clinical Chemistry and Laboratory Medicine
|
December 20, 2019
Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM
Michel R Langlois, Børge G Nordestgaard, Anne Langsted, et al.
Atherosclerosis
|
January 14, 2020
Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM
Børge G Nordestgaard, Michel R Langlois, Anne Langsted, et al.
The Lancet. Diabetes & Endocrinology
|
June 2, 2016
Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel
Raul D Santos, Samuel S Gidding, Robert A Hegele, et al.
European Heart Journal
|
August 20, 2013
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society
Børge G Nordestgaard, M John Chapman, Steve E Humphries, et al.
Atherosclerosis. Supplements
|
September 16, 2011
Familial hypercholesterolaemia: a model of care for Australasia
Gerald F Watts, David R Sullivan, Nicola Poplawski, et al.
Page
of 71
Search research articles
Search
Showing results (681-690 of 706) with videos related to
Sort By:
Page
of 71
The Canadian Journal of Cardiology
|
August 11, 2018
Simplified Canadian Definition for Familial Hypercholesterolemia
Isabelle Ruel, Diane Brisson, Sumayah Aljenedil, et al.
Journal of Lipid Research
|
April 11, 2025
Statin effects on the lipidome: Predicting statin usage and implications for cardiovascular risk prediction
Changyu Yi, Kevin Huynh, Yvette Schooneveldt, et al.
European Heart Journal
|
August 29, 2022
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement
Florian Kronenberg, Samia Mora, Erik S G Stroes, et al.
The Lancet. Diabetes & Endocrinology
|
April 16, 2014
The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
Robert A Hegele, Henry N Ginsberg, M John Chapman, et al.
European Heart Journal
|
April 27, 2017
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
Brian A Ference, Henry N Ginsberg, Ian Graham, et al.
Clinical Chemistry and Laboratory Medicine
|
December 20, 2019
Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM
Michel R Langlois, Børge G Nordestgaard, Anne Langsted, et al.
Atherosclerosis
|
January 14, 2020
Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM
Børge G Nordestgaard, Michel R Langlois, Anne Langsted, et al.
The Lancet. Diabetes & Endocrinology
|
June 2, 2016
Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel
Raul D Santos, Samuel S Gidding, Robert A Hegele, et al.
European Heart Journal
|
August 20, 2013
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society
Børge G Nordestgaard, M John Chapman, Steve E Humphries, et al.
Atherosclerosis. Supplements
|
September 16, 2011
Familial hypercholesterolaemia: a model of care for Australasia
Gerald F Watts, David R Sullivan, Nicola Poplawski, et al.
Page
of 71